{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:14:10Z","timestamp":1791249250604,"version":"4.1.0"},"reference-count":76,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:p>There is an inverse correlation between exposure to sunlight (the major source of vitamin D) and the risk for prostate cancer, the most common noncutaneous cancer and second most common cause of death from cancer in American men. The active metabolite of vitamin D, 1\u03b1,25-dihydroxyvitamin D3 [1,25(OH)2D3] acting through the vitamin D receptor decreases prostate cancer cell growth and invasiveness. The precise mechanisms by which 1,25(OH)2D3 inhibits growth in prostate cancer have not been fully elucidated. Treatment with 1,25(OH)2D3 causes an accumulation in the G0\/G1 phase of the cell cycle in several prostate cancer cell lines. One potential target known to regulate the G0\/G1 to S phase transition is c-Myc, a transcription factor whose overexpression is associated with a number of cancers including prostate cancer. We find that 1,25(OH)2D3 reduces c-Myc expression in multiple prostate epithelial cell lines, including C4-2 cells, an androgen-independent prostate cancer cell line. Reducing c-Myc expression to the levels observed after 1,25(OH)2D3 treatment resulted in a comparable decrease in proliferation and G1 accumulation demonstrating that down-regulation of c-Myc is a major component in the growth-inhibitory actions of 1,25(OH)2D3. Treatment with 1,25(OH)2D3 resulted in a 50% decrease in c-Myc mRNA but a much more extensive reduction in c-Myc protein. Treatment with 1,25(OH)2D3 decreased c-Myc stability by increasing the proportion of c-Myc phosphorylated on T58, a glycogen synthase kinase-3\u03b2 site that serves as a signal for ubiquitin-mediated proteolysis. Thus, 1,25(OH)2D3 reduces both c-Myc mRNA levels and c-Myc protein stability to inhibit growth of prostate cancer cells.<\/jats:p>","DOI":"10.1210\/en.2008-1395","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T21:12:22Z","timestamp":1232658742000},"page":"2046-2054","source":"Crossref","is-referenced-by-count":78,"title":["1\u03b1,25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer Cells"],"prefix":"10.1210","volume":"150","author":[{"given":"JoyAnn N. Phillips","family":"Rohan","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Biology (J.N.P.R., N.L.W.), Baylor College of Medicine, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Weigel","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology (J.N.P.R., N.L.W.), Baylor College of Medicine, Houston, Texas 77030"},{"name":"Department of Scott Department of Urology (N.L.W.), Baylor College of Medicine, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2009,1,22]]},"reference":[{"key":"2020071620073503300_R1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1158\/1535-7163.MCT-05-0539","article-title":"Promise of vitamin D analogues in the treatment of hyperproliferative conditions.","volume":"5","author":"Masuda","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"2020071620073503300_R2","first-page":"265","article-title":"25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.","volume":"9","author":"Barreto","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020071620073503300_R3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1008923802001","article-title":"Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).","volume":"11","author":"Ahonen","year":"2000","journal-title":"Cancer Causes Control"},{"key":"2020071620073503300_R4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1158\/1055-9965.EPI-06-1053","article-title":"Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure.","volume":"16","author":"John","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020071620073503300_R5","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1158\/0008-5472.CAN-04-3134","article-title":"Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer.","volume":"65","author":"John","year":"2005","journal-title":"Cancer Res"},{"key":"2020071620073503300_R6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/djn152","article-title":"Serum vitamin D concentration and prostate cancer risk: a nested case-control study.","volume":"100","author":"Ahn","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2020071620073503300_R7","first-page":"263","article-title":"Molecular biology of the vitamin D hormone.","volume":"44","author":"Haussler","year":"1988","journal-title":"Recent Prog Horm Res"},{"key":"2020071620073503300_R8","first-page":"7122","article-title":"Growth inhibitory effects of 1\u03b1, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31.","volume":"61","author":"Moffatt","year":"2001","journal-title":"Cancer Res"},{"key":"2020071620073503300_R9","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/endo.132.5.7682937","article-title":"Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.","volume":"132","author":"Skowronski","year":"1993","journal-title":"Endocrinology"},{"key":"2020071620073503300_R10","first-page":"779","article-title":"A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.","volume":"60","author":"Blutt","year":"2000","journal-title":"Cancer Res"},{"key":"2020071620073503300_R11","first-page":"89","article-title":"Anti-tumor activity of calcitriol: pre-clinical and clinical studies.","author":"Trump","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071620073503300_R12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1210\/endo.138.4.5063","article-title":"1,25-Dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.","volume":"138","author":"Blutt","year":"1997","journal-title":"Endocrinology"},{"key":"2020071620073503300_R13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/endo.141.1.7289","article-title":"Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2.","volume":"141","author":"Blutt","year":"2000","journal-title":"Endocrinology"},{"key":"2020071620073503300_R14","first-page":"2822","article-title":"20-Epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.","volume":"55","author":"Elstner","year":"1995","journal-title":"Cancer Res"},{"key":"2020071620073503300_R15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1005772432465","article-title":"Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.","volume":"42","author":"Simboli-Campbell","year":"1997","journal-title":"Breast Cancer Res Treat"},{"key":"2020071620073503300_R16","first-page":"3898","article-title":"Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-\u03b1,25-dihydroxyvitamin D3.","volume":"45","author":"Studzinski","year":"1985","journal-title":"Cancer Res"},{"key":"2020071620073503300_R17","doi-asserted-by":"crossref","first-page":"46862","DOI":"10.1074\/jbc.M306340200","article-title":"Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.","volume":"278","author":"Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071620073503300_R18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0022-5347(01)69892-6","article-title":"Insulin-like growth factor binding protein-3 mediates 1\u03b1,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21\/WAF1.","volume":"165","author":"Boyle","year":"2001","journal-title":"J Urol"},{"key":"2020071620073503300_R19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1210\/en.2001-210109","article-title":"p53 is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells.","volume":"144","author":"Polek","year":"2003","journal-title":"Endocrinology"},{"key":"2020071620073503300_R20","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/MCB.19.7.4672","article-title":"c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.","volume":"19","author":"Mateyak","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2020071620073503300_R21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1582-4934.2002.tb00183.x","article-title":"Chromosome-mediated alterations of the MYC gene in human cancer.","volume":"6","author":"Popescu","year":"2002","journal-title":"J Cell Mol Med"},{"key":"2020071620073503300_R22","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1158\/0008-5472.CAN-07-0673","article-title":"Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.","volume":"67","author":"Lapointe","year":"2007","journal-title":"Cancer Res"},{"key":"2020071620073503300_R23","first-page":"524","article-title":"Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.","volume":"57","author":"Jenkins","year":"1997","journal-title":"Cancer Res"},{"key":"2020071620073503300_R24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0092-8674(89)90625-9","article-title":"Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.","volume":"56","author":"Thompson","year":"1989","journal-title":"Cell"},{"key":"2020071620073503300_R25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pros.20200","article-title":"Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.","volume":"63","author":"Williams","year":"2005","journal-title":"Prostate"},{"key":"2020071620073503300_R26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0960-0760(92)90190-T","article-title":"Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.","volume":"43","author":"Thompson","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071620073503300_R27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","article-title":"Myc-driven murine prostate cancer shares molecular features with human prostate tumors.","volume":"4","author":"Ellwood-Yen","year":"2003","journal-title":"Cancer Cell"},{"key":"2020071620073503300_R28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1396.022","article-title":"Transcriptional regulation of telomerase activity: roles of the Ets transcription factor family.","volume":"1114","author":"Dwyer","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"2020071620073503300_R29","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1016\/S0021-9258(18)67633-1","article-title":"Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact.","volume":"261","author":"Dean","year":"1986","journal-title":"J Biol Chem"},{"key":"2020071620073503300_R30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cellsig.2007.10.010","article-title":"Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells.","volume":"20","author":"Sun","year":"2008","journal-title":"Cell Signal"},{"key":"2020071620073503300_R31","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway.","volume":"281","author":"He","year":"1998","journal-title":"Science"},{"key":"2020071620073503300_R32","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1074\/jbc.274.13.8437","article-title":"c-myc intron element-binding proteins are required for 1, 25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4","volume":"274","author":"Pan","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071620073503300_R33","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/MCB.4.11.2486","article-title":"Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.","volume":"4","author":"Hann","year":"1984","journal-title":"Mol Cell Biol"},{"key":"2020071620073503300_R34","doi-asserted-by":"crossref","first-page":"9085","DOI":"10.1073\/pnas.0402770101","article-title":"The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.","volume":"101","author":"Welcker","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071620073503300_R35","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1158\/0008-5472.CAN-03-3619","article-title":"CCAAT\/enhancer-binding protein \u0394: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.","volume":"65","author":"Ikezoe","year":"2005","journal-title":"Cancer Res"},{"key":"2020071620073503300_R36","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.1158\/0008-5472.CAN-05-1435","article-title":"Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.","volume":"65","author":"Moreno","year":"2005","journal-title":"Cancer Res"},{"key":"2020071620073503300_R37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pros.20212","article-title":"Role of insulin-like growth factor binding proteins in 1\u03b1,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.","volume":"64","author":"Stewart","year":"2005","journal-title":"Prostate"},{"key":"2020071620073503300_R38","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1128\/MCB.25.8.2885-2898.2005","article-title":"Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.","volume":"25","author":"Narayanan","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2020071620073503300_R39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsbmb.2005.06.011","article-title":"Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.","volume":"97","author":"Stewart","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071620073503300_R40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1083\/jcb.200102028","article-title":"Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of \u03b2-catenin signaling.","volume":"154","author":"Palmer","year":"2001","journal-title":"J Cell Biol"},{"key":"2020071620073503300_R41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/35078555","article-title":"Regulation of c-myc expression by PDGF through Rho GTPases.","volume":"3","author":"Chiariello","year":"2001","journal-title":"Nat Cell Biol"},{"key":"2020071620073503300_R42","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1038\/sj.onc.1208002","article-title":"Prolactin induces c-Myc expression and cell survival through activation of Src\/Akt pathway in lymphoid cells.","volume":"23","author":"Dominguez-Caceres","year":"2004","journal-title":"Oncogene"},{"key":"2020071620073503300_R43","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","article-title":"Jak2 is involved in c-Myc induction by Bcr-Abl.","volume":"21","author":"Xie","year":"2002","journal-title":"Oncogene"},{"key":"2020071620073503300_R44","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.emboj.7600217","article-title":"Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.","volume":"23","author":"Yada","year":"2004","journal-title":"EMBO J"},{"key":"2020071620073503300_R45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9440(10)65554-X","article-title":"Genetic alterations in hormone-refractory recurrent prostate carcinomas.","volume":"153","author":"Nupponen","year":"1998","journal-title":"Am J Pathol"},{"key":"2020071620073503300_R46","first-page":"2720","article-title":"Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.","volume":"58","author":"Vlietstra","year":"1998","journal-title":"Cancer Res"},{"key":"2020071620073503300_R47","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/pros.20745","article-title":"Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.","volume":"68","author":"Wu","year":"2008","journal-title":"Prostate"},{"key":"2020071620073503300_R48","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"2020071620073503300_R49","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1038\/onc.2008.183","article-title":"TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation.","volume":"27","author":"Sun","year":"2008","journal-title":"Oncogene"},{"key":"2020071620073503300_R50","first-page":"1370","article-title":"Inhibitory effects of 1\u03b1a,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.","volume":"15","author":"Jensen","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2020071620073503300_R51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1210\/endo.141.1.7341","article-title":"Vitamin D and prostate cancer.","volume":"141","author":"Feldman","year":"2000","journal-title":"Endocrinology"},{"key":"2020071620073503300_R52","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/jn\/133.7.2461S","article-title":"Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer.","volume":"133","author":"Peehl","year":"2003","journal-title":"J Nutr"},{"key":"2020071620073503300_R53","first-page":"805","article-title":"Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.","volume":"54","author":"Peehl","year":"1994","journal-title":"Cancer Res"},{"key":"2020071620073503300_R54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3181\/00379727-221-44389","article-title":"Vitamin D and prostate cancer.","volume":"221","author":"Blutt","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071620073503300_R55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1677\/erc.0.0100131","article-title":"The role of vitamin D and retinoids in controlling prostate cancer progression.","volume":"10","author":"Peehl","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"2020071620073503300_R56","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1096\/fasebj.7.10.8393817","article-title":"The retinoblastoma gene: role in cell cycle control and cell differentiation.","volume":"7","author":"Wiman","year":"1993","journal-title":"FASEB J"},{"key":"2020071620073503300_R57","first-page":"7","article-title":"Control of the G1\/S transition.","volume":"29","author":"Reed","year":"1997","journal-title":"Cancer Surv"},{"key":"2020071620073503300_R58","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0955-0674(95)80067-0","article-title":"What is the restriction point?","volume":"7","author":"Zetterberg","year":"1995","journal-title":"Curr Opin Cell Biol"},{"key":"2020071620073503300_R59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001813-199304000-00012","article-title":"Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone.","volume":"4","author":"Saunders","year":"1993","journal-title":"Anticancer Drugs"},{"key":"2020071620073503300_R60","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0959-8049(98)00267-6","article-title":"Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression.","volume":"34","author":"Tong","year":"1998","journal-title":"Eur J Cancer"},{"key":"2020071620073503300_R61","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0090-4295(97)00390-7","article-title":"Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: a novel therapy in prostate cancer.","volume":"50","author":"Balaji","year":"1997","journal-title":"Urology"},{"key":"2020071620073503300_R62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(01)02114-7","article-title":"Pathways governing G1\/S transition and their response to DNA damage.","volume":"490","author":"Bartek","year":"2001","journal-title":"FEBS Lett"},{"key":"2020071620073503300_R63","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1210\/endo.139.3.5770","article-title":"Antiproliferative effect of 1\u03b1,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.","volume":"139","author":"Zhuang","year":"1998","journal-title":"Endocrinology"},{"key":"2020071620073503300_R64","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/onc.2008.55","article-title":"A role for Myc in facilitating transcription activation by E2F1.","volume":"27","author":"Leung","year":"2008","journal-title":"Oncogene"},{"key":"2020071620073503300_R65","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1128\/MCB.17.9.5227","article-title":"Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals.","volume":"17","author":"Sears","year":"1997","journal-title":"Mol Cell Biol"},{"key":"2020071620073503300_R66","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/MCB.7.12.4513","article-title":"Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3\u2032 untranslated sequences.","volume":"7","author":"Jones","year":"1987","journal-title":"Mol Cell Biol"},{"key":"2020071620073503300_R67","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/j.1460-2075.1985.tb03885.x","article-title":"Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.","volume":"4","author":"Rabbitts","year":"1985","journal-title":"EMBO J"},{"key":"2020071620073503300_R68","doi-asserted-by":"crossref","first-page":"34725","DOI":"10.1074\/jbc.R600017200","article-title":"The ins and outs of MYC regulation by posttranslational mechanisms.","volume":"281","author":"Vervoorts","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071620073503300_R69","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcb.21884","article-title":"Rcl is a novel ETV1\/ER81 target gene upregulated in breast tumors.","volume":"105","author":"Shin","year":"2008","journal-title":"J Cell Biochem"},{"key":"2020071620073503300_R70","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1101\/gad.836800","article-title":"Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.","volume":"14","author":"Sears","year":"2000","journal-title":"Genes Dev"},{"key":"2020071620073503300_R71","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4161\/cc.3.9.1145","article-title":"The life cycle of C-myc: from synthesis to degradation.","volume":"3","author":"Sears","year":"2004","journal-title":"Cell Cycle"},{"key":"2020071620073503300_R72","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","article-title":"Constitutive transcriptional activation by a \u03b2-catenin-Tcf complex in APC\u2212\/\u2212 colon carcinoma.","volume":"275","author":"Korinek","year":"1997","journal-title":"Science"},{"key":"2020071620073503300_R73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2005.06.004","article-title":"Roles and regulation of Wnt signaling and \u03b2-catenin in prostate cancer.","volume":"237","author":"Verras","year":"2006","journal-title":"Cancer Lett"},{"key":"2020071620073503300_R74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1399-5618.2002.40201.x","article-title":"Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.","volume":"4","author":"Li","year":"2002","journal-title":"Bipolar Disord"},{"key":"2020071620073503300_R75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0993-56","article-title":"Point mutations in the c-Myc transactivation domain are common in Burkitt\u2019s lymphoma and mouse plasmacytomas.","volume":"5","author":"Bhatia","year":"1993","journal-title":"Nat Genet"},{"key":"2020071620073503300_R76","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1074\/jbc.271.10.5513","article-title":"Functional analysis of Burkitt\u2019s lymphoma mutant c-Myc proteins.","volume":"271","author":"Smith-Sorensen","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/150\/5\/2046\/9002295\/endo2046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/150\/5\/2046\/9002295\/endo2046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T08:32:01Z","timestamp":1632990721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/150\/5\/2046\/2455790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,22]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2008-1395","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,22]]}}}